Middletown, DE -- (SBWIRE) -- 10/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Garmin Ltd.(NASDAQ:GRMN), Splunk Inc(NASDAQ:SPLK), Incyte Corporation(NASDAQ:INCY), Biogen Idec Inc(NASDAQ:BIIB)
Garmin Ltd.(NASDAQ:GRMN) was a volume gainer of 1.33 million shares and the average volume of the stock remained 1.78 million shares. The stock opened the session at $47.13 and finished at the end of the day at $47.13 and the stock escalated +0.14%.The market capitalization of the stock remained 9.21 billion. The half-yearly trend of the stock remained positive/negative +40.31%. Garmin Ltd., together with its subsidiaries, designs, develops, manufactures, and markets hand-held, portable and fixed-mount global positioning system (GPS) enabled products and other navigation, communication, and information products for the automotive/mobile, outdoor, fitness, marine, and general aviation markets worldwide.
For How Long GRMN will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Splunk Inc(NASDAQ:SPLK) exchanged 1.32 million shares and the average volume remained 1.35 million shares. The stock closed the session at $62.95 with the gain of +3.78%. Tracking three months and 6 months trends, the stock was at of +27.64% and +57.73%, respectively. Splunk, Inc. provides software solutions that provide real-time operational intelligence. It offers Splunk, an engine that collects, indexes, and harnesses machine data generated by physical, virtual or in the cloud IT infrastructure; and Splunk Storm, a cloud version of Splunk to analyze cloud based applications.
Will SPLK Continue To Move Higher? Find Out Here
Incyte Corporation(NASDAQ:INCY) decreased -1.74% and its closing price was $40.11. The volume of the stock was 1.32 million shares and the average volume remained 1.67 million shares. Yesterday, the stock traded amid the day price range of $39.92 - $41.95. The market capitalization of the stock remained 6.14 billion. The beta of the stock remained 1.99. Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs for oncology and inflammation. The company markets JAKAFI, an oral janus associated kinase (JAK) inhibitor for the treatment of patients with intermediate or high-risk myelofibrosis (MF).
Will INCY Get Buyers Even After The Recent Rally? Find Out Here
Biogen Idec Inc(NASDAQ:BIIB) exchanged 1.33 million shares in the previous trading session, and its average trading remained 1.07 million shares. BIIB advanced +2.76% and it closed the trading at $240.30. The market capitalization of the stock remained 57.11 billion. YTD trend of the stock was positive +64.53%. Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS).
For How Long BIIB’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)